The global market for Biobanks was estimated at US$91.6 Billion in 2024 and is projected to reach US$143.3 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Biobanks market.
The development and utilization of biobanks have been significantly enhanced by advancements in technology and data management. Modern biobanks employ sophisticated systems for sample collection, processing, storage, and retrieval, ensuring the integrity and traceability of specimens. The integration of high-throughput sequencing, bioinformatics, and data analytics enables the extraction of valuable insights from biobank samples, facilitating breakthroughs in medical research. Moreover, the implementation of standardized protocols and quality control measures ensures the consistency and reproducibility of research findings. Biobanks also play a crucial role in large-scale population studies and longitudinal research, providing a foundation for understanding the genetic, environmental, and lifestyle factors that contribute to health and disease.
The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers. Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.
Global Biobanks Market - Key Trends & Drivers Summarized
Biobanks are specialized repositories that collect, store, and manage biological samples such as blood, tissue, DNA, and other bodily fluids for use in research and clinical studies. These samples, along with associated data, are invaluable resources for advancing medical research, understanding diseases, and developing new treatments and diagnostics. Biobanks support a wide range of research areas, including genomics, personalized medicine, epidemiology, and translational research. They provide researchers with access to high-quality, well-characterized specimens that are critical for studying disease mechanisms, identifying biomarkers, and testing new drugs and therapies.The development and utilization of biobanks have been significantly enhanced by advancements in technology and data management. Modern biobanks employ sophisticated systems for sample collection, processing, storage, and retrieval, ensuring the integrity and traceability of specimens. The integration of high-throughput sequencing, bioinformatics, and data analytics enables the extraction of valuable insights from biobank samples, facilitating breakthroughs in medical research. Moreover, the implementation of standardized protocols and quality control measures ensures the consistency and reproducibility of research findings. Biobanks also play a crucial role in large-scale population studies and longitudinal research, providing a foundation for understanding the genetic, environmental, and lifestyle factors that contribute to health and disease.
The growth in the biobank market is driven by several factors. Firstly, the increasing prevalence of chronic and complex diseases, such as cancer and cardiovascular disorders, is driving the demand for biobanks to support research into new treatments and diagnostics. Secondly, the rise of personalized medicine and precision healthcare is boosting the need for well-characterized biological samples that can be used to develop targeted therapies and interventions. Thirdly, the growing focus on genetic and genomic research is expanding the use of biobank samples for studying the genetic basis of diseases and identifying novel biomarkers. Additionally, advancements in biobanking technologies, including automated storage systems and advanced data management platforms, are enhancing the efficiency and capabilities of biobanks. Lastly, increased funding and collaboration between academic institutions, healthcare organizations, and industry players are supporting the establishment and expansion of biobanks, driving market growth and fostering innovation in biomedical research.
Scope of Study:
The report analyzes the Biobanks market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Type (Physical / Real, Virtual); Product (Biobanking Equipment, Biobanking Consumables, Laboratory Information Management Systems); Application (Therapeutics, Drug Discovery & Clinical Research, Clinical Diagnostics, Other Applications)
- Geographic Regions/Countries: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Physical / Real segment, which is expected to reach US$108.4 Billion by 2030 with a CAGR of a 7.3%. The Virtual segment is also set to grow at 9.2% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $29.8 Billion in 2024, and China, forecasted to grow at an impressive 8.8% CAGR to reach $15.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Biobanks Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Biobanks Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Biobanks Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as AMS Biotechnology (Europe) Limited, Bay Biosciences LLC, BioIVT & Elevating Science, BioLifeSolutions Inc., Biovault Technical and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 99 companies featured in this Biobanks market report include:
- AMS Biotechnology (Europe) Limited
- Bay Biosciences LLC
- BioIVT & Elevating Science
- BioLifeSolutions Inc.
- Biovault Technical
- CENTOGENE NV
- CTI Biotech
- Cureline, Inc.
- Firalis S.A.
- Hamilton Company
- Merck KGaA
- ProteoGenex, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation, Inc.
- VWR International LLC
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AMS Biotechnology (Europe) Limited
- Bay Biosciences LLC
- BioIVT & Elevating Science
- BioLifeSolutions Inc.
- Biovault Technical
- CENTOGENE NV
- CTI Biotech
- Cureline, Inc.
- Firalis S.A.
- Hamilton Company
- Merck KGaA
- ProteoGenex, Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- US Biolab Corporation, Inc.
- VWR International LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 402 |
| Published | June 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 91.6 Billion |
| Forecasted Market Value ( USD | $ 143.3 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
